Tandem Diabetes Care, Inc.

TNDM

$18.34

Name : Tandem Diabetes Care, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $1,243,495,296.00

EPSttm : -3.03

Tandem Diabetes Care, Inc.

$18.34

1.45%

$0.27

Float Short %

13.06

Margin Of Safety %

Put/Call OI Ratio

0.79

EPS Next Q Diff

-0.11

EPS Last/This Y

-0.63

EPS This/Next Y

1.13

Price

18.36

Target Price

21.68

Analyst Recom

2.4

Performance Q

68.41

Relative Volume

Beta

1.65

Ticker: TNDM

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	TNDM	15.54	0.85	0.11	12273
2025-10-21	TNDM	15.39	0.83	0.40	12539
2025-10-22	TNDM	14.95	0.83	1.00	12547
2025-10-23	TNDM	14.65	0.84	0.01	12569
2025-10-24	TNDM	14.94	0.84	0.13	12520
2025-10-27	TNDM	14.95	0.84	0.09	12552
2025-10-28	TNDM	15.09	0.83	0.16	12589
2025-10-29	TNDM	15.2	0.82	0.01	12710
2025-10-30	TNDM	14.6	0.82	0.18	12739
2025-10-31	TNDM	14	0.81	2.87	12872
2025-11-03	TNDM	14.36	0.82	0.18	12933
2025-11-04	TNDM	15.21	0.82	0.06	12929
2025-11-05	TNDM	14.66	0.83	1.70	12871
2025-11-06	TNDM	13.32	0.85	0.61	13014
2025-11-07	TNDM	16.26	0.81	0.13	17155
2025-11-10	TNDM	16.38	0.85	0.07	16907
2025-11-11	TNDM	17.53	0.85	0.57	16939
2025-11-12	TNDM	18.06	0.86	0.13	17821
2025-11-13	TNDM	17.53	0.84	0.22	18437
2025-11-14	TNDM	18.59	0.83	0.03	18637
2025-11-17	TNDM	18.35	0.79	0.46	19062
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	TNDM	15.54	7.3	114.2	-2.18
2025-10-21	TNDM	15.38	7.3	118.5	-2.18
2025-10-22	TNDM	14.96	7.3	119.8	-2.18
2025-10-23	TNDM	14.65	7.3	119.2	-2.18
2025-10-24	TNDM	14.94	5.6	116.4	-2.19
2025-10-27	TNDM	14.94	5.6	117.8	-2.19
2025-10-28	TNDM	15.10	5.6	117.0	-2.19
2025-10-29	TNDM	15.17	5.6	117.4	-2.19
2025-10-30	TNDM	14.59	5.6	120.4	-2.19
2025-10-31	TNDM	14.00	5.6	120.7	-2.19
2025-11-03	TNDM	14.35	5.6	116.0	-2.19
2025-11-04	TNDM	15.21	5.6	113.7	-2.19
2025-11-05	TNDM	14.66	5.6	120.3	-2.19
2025-11-06	TNDM	13.33	5.6	124.1	-2.19
2025-11-07	TNDM	16.26	5.6	102.6	-2.19
2025-11-10	TNDM	16.37	88.7	119.7	-2.19
2025-11-11	TNDM	17.52	88.7	115.2	-2.01
2025-11-12	TNDM	18.08	88.7	118.8	-2.01
2025-11-13	TNDM	17.52	88.7	123.0	-2.02
2025-11-14	TNDM	18.60	82.2	116.7	-2.02
2025-11-17	TNDM	18.36	84.1	121.9	-2.10
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	TNDM	3.56	12.44	13.87
2025-10-21	TNDM	3.56	12.44	13.87
2025-10-22	TNDM	3.56	12.44	13.87
2025-10-23	TNDM	3.56	12.44	13.87
2025-10-24	TNDM	3.56	12.44	13.87
2025-10-27	TNDM	3.53	11.36	13.81
2025-10-28	TNDM	3.60	11.36	13.81
2025-10-29	TNDM	3.60	11.36	13.81
2025-10-30	TNDM	3.60	11.36	13.81
2025-10-31	TNDM	3.60	11.36	13.81
2025-11-03	TNDM	3.60	8.10	13.81
2025-11-04	TNDM	3.60	8.10	13.81
2025-11-05	TNDM	3.60	8.10	13.81
2025-11-06	TNDM	3.60	8.10	13.81
2025-11-07	TNDM	3.60	8.10	13.81
2025-11-10	TNDM	3.59	5.18	13.76
2025-11-11	TNDM	3.59	5.18	13.76
2025-11-12	TNDM	3.59	5.18	13.06
2025-11-13	TNDM	3.59	5.18	13.06
2025-11-14	TNDM	3.59	5.18	13.06
2025-11-17	TNDM	3.59	9.38	13.06
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.31

Avg. EPS Est. Current Quarter

-0.07

Avg. EPS Est. Next Quarter

-0.42

Insider Transactions

3.59

Institutional Transactions

9.38

Beta

1.65

Average Sales Estimate Current Quarter

276

Average Sales Estimate Next Quarter

248

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

88.2

Max Drawdown 5-Year %

-93.4

Target Price

21.68

P/E

Forward P/E

PEG

P/S

1.23

P/B

9.35

P/Free Cash Flow

EPS

-3.05

Average EPS Est. Cur. Y

-2.1

EPS Next Y. (Est.)

-0.97

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-20.2

Relative Volume

Return on Equity vs Sector %

-179.9

Return on Equity vs Industry %

-170.9

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.08

EBIT Estimation

121.9

Tandem Diabetes Care, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 2650

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

stock quote shares TNDM – Tandem Diabetes Care, Inc. Stock Price stock today

news today TNDM – Tandem Diabetes Care, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch TNDM – Tandem Diabetes Care, Inc. yahoo finance google finance

stock history TNDM – Tandem Diabetes Care, Inc. invest stock market

stock prices TNDM premarket after hours

ticker TNDM fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: TNDM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y